Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lambert

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Diseases of the Colon and Rectum|July 9, 2019
Identification of Collagenolytic Bacteria in Human Samples: Screening Methods and Clinical Implications for Resolving and Preventing Anastomotic Leaks and Wound ComplicationsKristina L Guyton, Zoe C Levine, Ann C Lowry, et al.
Journal of Personalized Medicine|December 24, 2021
Restoration of Normal NF1 Function with Antisense Morpholino Treatment of Recurrent Pathogenic Patient-Specific Variant c.1466A>G; p.Y489CElias K Awad, Marc Moore, Hui Liu, et al.
Health Services Research|December 13, 2016
The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Mental Health Financial Requirements among Commercial "Carve-In" PlansSarah A Friedman, Amber G Thalmayer, Francisca Azocar, et al.
Frontiers in Immunology|September 8, 2016
DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza DiseaseLaura Lambert, Ekaterina Kinnear, Jacqueline U McDonald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2017
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower DosesAnnette B Vogel, Laura Lambert, Ekaterina Kinnear, et al.
Frontiers in Medicine|August 5, 2021
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide TherapyMichiel Van de Voorde, Charlotte Duchemin, Reinhard Heinke, et al.
Scientific Reports|July 2, 2025
Quantification of trace <sup>227</sup>Ac and other radionuclidic impurities in mass-separated <sup>225</sup>Ac samples produced at CERN-MEDICISJake D Johnson, Cyril Bernerd, Frank Bruchertseifer, et al.
Frontiers in Medicine|September 23, 2021
The CERN-MEDICIS Isotope Separator BeamlineYisel Martinez Palenzuela, Vincent Barozier, Eric Chevallay, et al.
Scientific Reports|January 24, 2023
Resonant laser ionization and mass separation of <sup>225</sup>AcJake D Johnson, Michael Heines, Frank Bruchertseifer, et al.
Molecular Therapy. Nucleic Acids|April 18, 2022
Targeted exon skipping of <i>NF1</i> exon 17 as a therapeutic for neurofibromatosis type IAndré Leier, Marc Moore, Hui Liu, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Diseases of the Colon and Rectum|July 9, 2019
Identification of Collagenolytic Bacteria in Human Samples: Screening Methods and Clinical Implications for Resolving and Preventing Anastomotic Leaks and Wound ComplicationsKristina L Guyton, Zoe C Levine, Ann C Lowry, et al.
Journal of Personalized Medicine|December 24, 2021
Restoration of Normal NF1 Function with Antisense Morpholino Treatment of Recurrent Pathogenic Patient-Specific Variant c.1466A>G; p.Y489CElias K Awad, Marc Moore, Hui Liu, et al.
Health Services Research|December 13, 2016
The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Mental Health Financial Requirements among Commercial "Carve-In" PlansSarah A Friedman, Amber G Thalmayer, Francisca Azocar, et al.
Frontiers in Immunology|September 8, 2016
DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza DiseaseLaura Lambert, Ekaterina Kinnear, Jacqueline U McDonald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 26, 2017
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower DosesAnnette B Vogel, Laura Lambert, Ekaterina Kinnear, et al.
Frontiers in Medicine|August 5, 2021
Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide TherapyMichiel Van de Voorde, Charlotte Duchemin, Reinhard Heinke, et al.
Scientific Reports|July 2, 2025
Quantification of trace <sup>227</sup>Ac and other radionuclidic impurities in mass-separated <sup>225</sup>Ac samples produced at CERN-MEDICISJake D Johnson, Cyril Bernerd, Frank Bruchertseifer, et al.
Frontiers in Medicine|September 23, 2021
The CERN-MEDICIS Isotope Separator BeamlineYisel Martinez Palenzuela, Vincent Barozier, Eric Chevallay, et al.
Scientific Reports|January 24, 2023
Resonant laser ionization and mass separation of <sup>225</sup>AcJake D Johnson, Michael Heines, Frank Bruchertseifer, et al.
Molecular Therapy. Nucleic Acids|April 18, 2022
Targeted exon skipping of <i>NF1</i> exon 17 as a therapeutic for neurofibromatosis type IAndré Leier, Marc Moore, Hui Liu, et al.
Pageof 7